Zymergen co-founders Zach Serber, Josh Hoffman, and Jed Dean (Zymergen via website)
Zymergen's sudden implosion shocked biotech. A lingering loan could make things even worse
As former synbio unicorn Zymergen picks up the pieces from its spectacular implosion Tuesday, an outstanding loan from Perceptive Advisors — the only blue-chip biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
